HRSA loan repayment program aims to boost opioid treatment access

Jan 07, 2019 - 02:49 PM
hrsa-service-corps

The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance in exchange for their service on the front lines of the opioid crisis in underserved communities. The National Health Service Corps Substance Use Disorder Workforce Loan Repayment Program will boost access to preventive, treatment and recovery services for those struggling with substance use disorder, according to HRSA. Clinicians accepted to the program may receive up to $75,000 for three years of full-time service at a health care facility that has been designated by HRSA as an NHSC-approved substance use disorder site. A part-time service option also is available. Applications are due Feb. 21. 
 

Related News Articles

Headline
White House announces deals with Eli Lilly, Novo Nordisk to lower drug costs 
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
Study examines increase in states banning prior authorization in private health plans for OUD medications
A Health Affairs study published Nov. 3 examined an increase in states banning prior authorizations in private insurance plans for opioid use disorder…
Headline
AHA toolkit includes resources to promote 2026 open enrollment 
The AHA has released a social media toolkit with sample posts and graphics encouraging people to sign up for 2026 health coverage via the Health Insurance…
Headline
Cigna announces new pricing model that would share negotiated discounts with consumers
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
KFF analysis highlights limited physician access in Medicare Advantage plans
A new report from KFF reveals that Medicare Advantage enrollees had access to just 48% of the physicians available to Traditional Medicare beneficiaries in…
Headline
Report finds launch prices for new drugs are significantly higher, exceed inflation
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…